Follow The Filings

ONMD OneMedNet

OneMedNet earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -0.04 —
Rev — $900.0K —

Insider trades

Open-market buys and sales by ONMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ONMD insider trades
  • $4.2M bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Thomas Kosasa Director
    Buy
    $750K 129,758 shares at $5.78 +7% to stake
    Traded Oct 7 Filed Oct 13
  2. Jeffrey Yu Chief Medical Officer
    Buy
    $250K 45,126 shares at $5.54 +5.3% to stake
    Traded Oct 9 Filed Oct 13
  3. Jeffrey Yu Chief Medical Officer
    Buy
    $90K 142,857 shares at $0.6300 +1.6% to stake
    Traded Sep 10 Filed Sep 14
  4. Thomas Kosasa Director
    Buy
    $1M 1,449,275 shares at $0.6900 +8.5% to stake
    Traded Jul 30 Filed Aug 7
  5. Aaron Green CEO
    Buy
    $21K 36,650 shares at $0.5700 +2% to stake
    Traded Jun 23 Filed Jun 24
  6. Jeffrey Yu Chief Medical Officer
    Buy
    $100K 158,730 shares at $0.6300 +1.8% to stake
    Traded Jun 23 Filed Jun 24
  7. Jeffrey Yu Chief Medical Officer
    Buy
    $100K 172,414 shares at $0.5800 +2% to stake
    Traded Jun 16 Filed Jun 17
  8. Aaron Green CEO
    Buy
    $31K 55,622 shares at $0.5500 +3.1% to stake
    Traded Jun 12–15 Filed Jun 16
  9. Thomas Kosasa Director
    Buy
    $100K 158,730 shares at $0.6300 +0.9% to stake
    Traded Jun 12 Filed Jun 15
  10. Thomas Kosasa Director
    Buy
    $250K 268,817 shares at $0.9300 +1.6% to stake
    Traded May 18 Filed May 20
  11. Jeffrey Yu Chief Medical Officer
    Buy
    $750K 903,614 shares at $0.8300 +12% to stake
    Traded Apr 1 Filed Apr 24
  12. Thomas Kosasa Director
    Buy
    $750K 876,136 shares at $0.8600 +5.6% to stake
    Traded Feb 6–Apr 23 Filed Apr 24
  13. Jeffrey Yu Chief Medical Officer
    Buy
    $960K 2,010,479 shares at $0.4800 +40% to stake
    Traded Jun 20, 2025–Sep 25, 2025 Filed Nov 26, 2025
  14. Jeffrey Yu Chief Medical Officer
    Buy
    $8,929 9,540 shares at $0.9400 +0.3% to stake
    Traded Feb 1, 2024–Dec 18, 2024 Filed Nov 26, 2025
  15. Thomas Kosasa Director
    Buy
    $1M 1,879,871 shares at $0.5600 +14% to stake
    Traded Apr 21, 2025–Sep 24, 2025 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants and 6 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 8.01
424B3
424B3
8-K 3.03,5.03,9.01
8-K 5.02,5.07,9.01
424B3
424B3
DEF 14A
10-Q
8-K 5.08,8.01
424B3
S-1/A
8-K 1.01,9.01
S-1
10-Q
424B3
10-K/A
8-K 3.01
424B3
10-K
8-K 5.07,8.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.